Clinical Trial Update: A Phase Ib Study of Fruquintinib in 3rd Line mCRC [Phase 1, Phase 2]

View source ↗

Summary

Phase Ib/Phase II trial update of Fruquintinib in third-line colorectal cancer shows completed status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Fruquintinib (fruquintinib)

Snippet

Sponsor: Hutchison Medipharma Limited | Conditions: Colorectal Cancer | Phase 1, Phase 2 | Status: COMPLETED